| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |